US 10034866
Inhalable medicament comprising tiotropium
granted A61KA61K31/439A61K47/10
Quick answer
US patent 10034866 (Inhalable medicament comprising tiotropium) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/439, A61K47/10, A61K47/12, A61K9/008